Connection

Elizabeth Garrett-Mayer to Myelodysplastic Syndromes

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Myelodysplastic Syndromes.
Elizabeth Garrett-Mayer
Connection Strength
0.089
Myelodysplastic Syndromes
  1. Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes. Leuk Res. 2008 Sep; 32(9):1439-47.
    View in: PubMed
    Score: 0.073
  2. A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia. Blood. 2007 Feb 15; 109(4):1387-94.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.